These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 1579596)
1. A comparative study on the vascular selectivity of lacidipine in the pithed rat. Micheli D; Massagrande M; Giacometti A; Collodel A; Gaviraghi G Pharmacology; 1992; 44(3):150-7. PubMed ID: 1579596 [TBL] [Abstract][Full Text] [Related]
2. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem. Quartaroli M; Gambini F; Tarter G; Micheli D; Trist DG; Gaviraghi G J Cardiovasc Pharmacol; 1991 Sep; 18(3):326-36. PubMed ID: 1720831 [TBL] [Abstract][Full Text] [Related]
3. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398 [TBL] [Abstract][Full Text] [Related]
4. Pharmacology of lacidipine, a vascular-selective calcium antagonist. Micheli D; Ratti E; Toson G; Gaviraghi G J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-8. PubMed ID: 1725998 [TBL] [Abstract][Full Text] [Related]
5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity. Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652 [TBL] [Abstract][Full Text] [Related]
6. Vascular effects of lacidipine: a review of animal and human data. Mancia G; Ferrari AU; Giannattasio C; Trazzi S J Hypertens Suppl; 1993 Mar; 11(1):S39-43. PubMed ID: 8483021 [TBL] [Abstract][Full Text] [Related]
7. The cardiac and vascular effects of lacidipine. Agabiti-Rosei E J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S1-5. PubMed ID: 8852537 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate. Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373 [TBL] [Abstract][Full Text] [Related]
9. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro. Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Yamaura T; Kase N; Kita H; Uematsu T Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142 [TBL] [Abstract][Full Text] [Related]
11. Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables. Motomura S; Wu ZJ; Hashimoto K Heart Vessels; 1993; 8(1):16-22. PubMed ID: 8454559 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Karasawa A; Kubo K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Moriyama T; Karasawa A Biol Pharm Bull; 1994 Nov; 17(11):1468-71. PubMed ID: 7703965 [TBL] [Abstract][Full Text] [Related]
14. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine. Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961 [TBL] [Abstract][Full Text] [Related]
15. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues. Angelico P; Guarneri L; Leonardi A; Testa R J Pharm Pharmacol; 1999 Jun; 51(6):709-14. PubMed ID: 10454048 [TBL] [Abstract][Full Text] [Related]
16. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency. Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156 [TBL] [Abstract][Full Text] [Related]
17. Effect of calcium channel blockers on postprandial gastrointestinal motility in the dog. De Ponti F; Einaudi A; Cosentino M; D'Angelo L; Frigo GM; Crema A J Pharm Pharmacol; 1992 Mar; 44(3):227-30. PubMed ID: 1354729 [TBL] [Abstract][Full Text] [Related]
18. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists. Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282 [TBL] [Abstract][Full Text] [Related]
19. Haemodynamic effects of lercanidipine in anaesthetized open-chest dogs. Sironi G; Montagna E; Greto L; Leonardi A; Testa R Arzneimittelforschung; 1996 Mar; 46(3):256-61. PubMed ID: 8901145 [TBL] [Abstract][Full Text] [Related]
20. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade. Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]